Lu, Chun-Yi
Chung, Ching-Hu
Huang, Li-Min
Kruger, Eliza
Tan, Seng-Chuen
Zhang, Xu-Hao
Chiu, Nan-Chang http://orcid.org/0000-0002-3966-5021
Article History
Received: 18 November 2019
Accepted: 17 August 2020
First Online: 28 August 2020
Change Date: 28 January 2021
Change Type: Update
Change Details: Following publication of the article, the authors have requested to add Additional file 2. Focus on the Patient, with the purpose of providing a summary of the study in non-technical language. In addition, the authors have flagged that following an update to the Markov model during the development of the manuscript (an update which resulted in modification of the estimated savings in the Results) some out-of-date values had been erroneously retained throughout the article.
Change Date: 17 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12962-021-00284-6
Ethics approval and consent to participate
: The current study is based on published data. Ethics approval and consent to participate are not applicable.
: Not applicable.
: X-H Zhang is employee of the GSK group of companies and holds shares in the GSK group of companies as part of her employee remuneration. CY Lu reports personal fees from the GSK group of companies and Pfizer, outside the submitted work. N-C Chiu reports grants from the Taiwanese CDC, Sanofi Pasteur, Novartis, Medigen, and the GSK group of companies, outside the submitted work. E Kruger and S-C Tan report that their organization received fees from the GSK group of companies for the conduct of the study and the development of the related publications, and outside of the submitted work. Other authors declare no conflict of interest.